OPA1 mutation affects autophagy and triggers senescence in autosomal dominant optic atrophy plus fibroblasts

Area of Science:

• Cell Biology
• Genetics
• Mitochondrial Medicine

Background:

• Mitochondrial diseases often involve impaired oxidative phosphorylation (OxPhos), but specific cellular consequences of gene mutations remain unclear.
• Effective treatments for these disorders are limited due to incomplete understanding of gene-specific cellular outcomes.
• Autosomal Dominant Optic Atrophy (ADOA) plus syndrome is a mitochondrial disorder with poorly understood cellular mechanisms.

Purpose of the Study:

• To investigate the cellular phenotypes and mitochondrial dysfunction in Autosomal Dominant Optic Atrophy (ADOA) plus syndrome.
• To explore the role of the Optic Atrophy 1 (OPA1) gene mutation in disease pathogenesis.
• To identify novel cellular mechanisms contributing to ADOA plus syndrome.

Main Methods:

• Utilized fibroblasts from an ADOA plus patient with an OPA1 gene mutation.
• Employed functional assays to assess mitochondrial function.
• Applied transcriptomic approaches to analyze cellular changes.
• Investigated mitochondrial dynamics and autophagic response.

Main Results:

• Fibroblasts with the OPA1 mutation showed a disrupted mitochondrial network and impaired mitochondrial function.
• Altered mitochondrial dynamics and a reduced autophagic response were observed.
• A premature senescence phenotype was identified in the patient-derived fibroblasts.
• The OPA1 gene mutation appears to play a role in inducing senescence in ADOA plus.

Conclusions:

• The OPA1 gene mutation significantly disrupts mitochondrial function and dynamics in ADOA plus syndrome.
• Premature cellular senescence is a novel phenotype associated with OPA1 mutations in this condition.
• Understanding these mechanisms, including senescence, may lead to new therapeutic strategies for ADOA plus.